New drug aims to boost insulin sensitivity in diabetes and obesity
NCT ID NCT07137585
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 20 times
Summary
This early-stage study tests an experimental drug called RO7204239 in 30 adults with type 2 diabetes who are also overweight or obese. The main goal is to see if the drug improves how the body uses insulin, compared to a placebo. Researchers will also check changes in blood sugar control and muscle health over 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Profil Institut für Stoffwechselforschung
Homburg, Saarland, 66421, Germany
Conditions
Explore the condition pages connected to this study.